Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis

Junko Kanno, Shigeo Kure, Ayumi Narisawa, Fumiaki Kamada, Masaru Takayanagi, Katsuya Yamamoto, Hisao Hoshino, Tomohide Goto, Takao Takahashi, Kazuhiro Haginoya, Shigeru Tsuchiya, Fritz A M Baumeister, Yuki Hasegawa, Yoko Aoki, Seiji Yamaguchi, Yoichi Matsubara

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Pyridoxine dependent seizure (PDS) is a disorder of neonates or infants with autosomal recessive inheritance characterized by seizures, which responds to pharmacological dose of pyridoxine. Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS. To elucidate further the genetic background of PDS, we screened for ALDH7A1 mutations in five PDS families (patients 1-5) that included four Orientals. Diagnosis as having PDS was confirmed by pyridoxine-withdrawal test. Exon sequencing analysis of patients 1-4 revealed eight ALDH7A1 mutations in compound heterozygous forms: five missense mutations, one nonsense mutation, one point mutation at the splicing donor site in intron 1, and a 1937-bp genomic deletion. The deletion included the entire exon 17, which was flanked by two Alu elements in introns 16 and 17. None of the mutations was found in 100 control chromosomes. In patient 5, no mutation was found by the exon sequencing analysis. Furthermore, expression level or nucleotide sequences of ALDH7A1 mRNA in lymphoblasts were normal. Plasma pipecolic acid concentration was not elevated in patient 5. These observations suggest that ALDH7A1 mutation is unlikely to be responsible for patient 5. Abnormal metabolism of GABA/glutamate in brain has long been suggested as the underlying pathophysiology of PDS. CSF glutamate concentration was elevated during the off- pyridoxine period in patient 3, but not in patient 2 or 5. These results suggest allelic and non-allelic heterogeneities of PDS, and that the CSF glutamate elevation does not directly correlate with the presence of ALDH7A1 mutations.

Original languageEnglish
Pages (from-to)384-389
Number of pages6
JournalMolecular Genetics and Metabolism
Volume91
Issue number4
DOIs
Publication statusPublished - 2007 Aug

Fingerprint

Pyridoxine
Mutation
Glutamic Acid
Exons
Introns
Alu Elements
Nonsense Codon
Missense Mutation
Pyridoxine-dependent epilepsy
Point Mutation
gamma-Aminobutyric Acid
Seizures
Chromosomes
Tissue Donors
Newborn Infant
Pharmacology
Metabolism
Messenger RNA
Brain
Nucleotides

Keywords

  • A large deletion
  • ALDH7A1 gene
  • Alu repeats
  • Convulsion
  • Genetic heterogeneity
  • Lymphoblasts
  • Pipecolic acid
  • Private mutations
  • RT-PCR analysis
  • Vitamin B

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. / Kanno, Junko; Kure, Shigeo; Narisawa, Ayumi; Kamada, Fumiaki; Takayanagi, Masaru; Yamamoto, Katsuya; Hoshino, Hisao; Goto, Tomohide; Takahashi, Takao; Haginoya, Kazuhiro; Tsuchiya, Shigeru; Baumeister, Fritz A M; Hasegawa, Yuki; Aoki, Yoko; Yamaguchi, Seiji; Matsubara, Yoichi.

In: Molecular Genetics and Metabolism, Vol. 91, No. 4, 08.2007, p. 384-389.

Research output: Contribution to journalArticle

Kanno, J, Kure, S, Narisawa, A, Kamada, F, Takayanagi, M, Yamamoto, K, Hoshino, H, Goto, T, Takahashi, T, Haginoya, K, Tsuchiya, S, Baumeister, FAM, Hasegawa, Y, Aoki, Y, Yamaguchi, S & Matsubara, Y 2007, 'Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis', Molecular Genetics and Metabolism, vol. 91, no. 4, pp. 384-389. https://doi.org/10.1016/j.ymgme.2007.02.010
Kanno, Junko ; Kure, Shigeo ; Narisawa, Ayumi ; Kamada, Fumiaki ; Takayanagi, Masaru ; Yamamoto, Katsuya ; Hoshino, Hisao ; Goto, Tomohide ; Takahashi, Takao ; Haginoya, Kazuhiro ; Tsuchiya, Shigeru ; Baumeister, Fritz A M ; Hasegawa, Yuki ; Aoki, Yoko ; Yamaguchi, Seiji ; Matsubara, Yoichi. / Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. In: Molecular Genetics and Metabolism. 2007 ; Vol. 91, No. 4. pp. 384-389.
@article{2c415ee0e6894a37909f848dfcbe6ca4,
title = "Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis",
abstract = "Pyridoxine dependent seizure (PDS) is a disorder of neonates or infants with autosomal recessive inheritance characterized by seizures, which responds to pharmacological dose of pyridoxine. Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS. To elucidate further the genetic background of PDS, we screened for ALDH7A1 mutations in five PDS families (patients 1-5) that included four Orientals. Diagnosis as having PDS was confirmed by pyridoxine-withdrawal test. Exon sequencing analysis of patients 1-4 revealed eight ALDH7A1 mutations in compound heterozygous forms: five missense mutations, one nonsense mutation, one point mutation at the splicing donor site in intron 1, and a 1937-bp genomic deletion. The deletion included the entire exon 17, which was flanked by two Alu elements in introns 16 and 17. None of the mutations was found in 100 control chromosomes. In patient 5, no mutation was found by the exon sequencing analysis. Furthermore, expression level or nucleotide sequences of ALDH7A1 mRNA in lymphoblasts were normal. Plasma pipecolic acid concentration was not elevated in patient 5. These observations suggest that ALDH7A1 mutation is unlikely to be responsible for patient 5. Abnormal metabolism of GABA/glutamate in brain has long been suggested as the underlying pathophysiology of PDS. CSF glutamate concentration was elevated during the off- pyridoxine period in patient 3, but not in patient 2 or 5. These results suggest allelic and non-allelic heterogeneities of PDS, and that the CSF glutamate elevation does not directly correlate with the presence of ALDH7A1 mutations.",
keywords = "A large deletion, ALDH7A1 gene, Alu repeats, Convulsion, Genetic heterogeneity, Lymphoblasts, Pipecolic acid, Private mutations, RT-PCR analysis, Vitamin B",
author = "Junko Kanno and Shigeo Kure and Ayumi Narisawa and Fumiaki Kamada and Masaru Takayanagi and Katsuya Yamamoto and Hisao Hoshino and Tomohide Goto and Takao Takahashi and Kazuhiro Haginoya and Shigeru Tsuchiya and Baumeister, {Fritz A M} and Yuki Hasegawa and Yoko Aoki and Seiji Yamaguchi and Yoichi Matsubara",
year = "2007",
month = "8",
doi = "10.1016/j.ymgme.2007.02.010",
language = "English",
volume = "91",
pages = "384--389",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis

AU - Kanno, Junko

AU - Kure, Shigeo

AU - Narisawa, Ayumi

AU - Kamada, Fumiaki

AU - Takayanagi, Masaru

AU - Yamamoto, Katsuya

AU - Hoshino, Hisao

AU - Goto, Tomohide

AU - Takahashi, Takao

AU - Haginoya, Kazuhiro

AU - Tsuchiya, Shigeru

AU - Baumeister, Fritz A M

AU - Hasegawa, Yuki

AU - Aoki, Yoko

AU - Yamaguchi, Seiji

AU - Matsubara, Yoichi

PY - 2007/8

Y1 - 2007/8

N2 - Pyridoxine dependent seizure (PDS) is a disorder of neonates or infants with autosomal recessive inheritance characterized by seizures, which responds to pharmacological dose of pyridoxine. Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS. To elucidate further the genetic background of PDS, we screened for ALDH7A1 mutations in five PDS families (patients 1-5) that included four Orientals. Diagnosis as having PDS was confirmed by pyridoxine-withdrawal test. Exon sequencing analysis of patients 1-4 revealed eight ALDH7A1 mutations in compound heterozygous forms: five missense mutations, one nonsense mutation, one point mutation at the splicing donor site in intron 1, and a 1937-bp genomic deletion. The deletion included the entire exon 17, which was flanked by two Alu elements in introns 16 and 17. None of the mutations was found in 100 control chromosomes. In patient 5, no mutation was found by the exon sequencing analysis. Furthermore, expression level or nucleotide sequences of ALDH7A1 mRNA in lymphoblasts were normal. Plasma pipecolic acid concentration was not elevated in patient 5. These observations suggest that ALDH7A1 mutation is unlikely to be responsible for patient 5. Abnormal metabolism of GABA/glutamate in brain has long been suggested as the underlying pathophysiology of PDS. CSF glutamate concentration was elevated during the off- pyridoxine period in patient 3, but not in patient 2 or 5. These results suggest allelic and non-allelic heterogeneities of PDS, and that the CSF glutamate elevation does not directly correlate with the presence of ALDH7A1 mutations.

AB - Pyridoxine dependent seizure (PDS) is a disorder of neonates or infants with autosomal recessive inheritance characterized by seizures, which responds to pharmacological dose of pyridoxine. Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS. To elucidate further the genetic background of PDS, we screened for ALDH7A1 mutations in five PDS families (patients 1-5) that included four Orientals. Diagnosis as having PDS was confirmed by pyridoxine-withdrawal test. Exon sequencing analysis of patients 1-4 revealed eight ALDH7A1 mutations in compound heterozygous forms: five missense mutations, one nonsense mutation, one point mutation at the splicing donor site in intron 1, and a 1937-bp genomic deletion. The deletion included the entire exon 17, which was flanked by two Alu elements in introns 16 and 17. None of the mutations was found in 100 control chromosomes. In patient 5, no mutation was found by the exon sequencing analysis. Furthermore, expression level or nucleotide sequences of ALDH7A1 mRNA in lymphoblasts were normal. Plasma pipecolic acid concentration was not elevated in patient 5. These observations suggest that ALDH7A1 mutation is unlikely to be responsible for patient 5. Abnormal metabolism of GABA/glutamate in brain has long been suggested as the underlying pathophysiology of PDS. CSF glutamate concentration was elevated during the off- pyridoxine period in patient 3, but not in patient 2 or 5. These results suggest allelic and non-allelic heterogeneities of PDS, and that the CSF glutamate elevation does not directly correlate with the presence of ALDH7A1 mutations.

KW - A large deletion

KW - ALDH7A1 gene

KW - Alu repeats

KW - Convulsion

KW - Genetic heterogeneity

KW - Lymphoblasts

KW - Pipecolic acid

KW - Private mutations

KW - RT-PCR analysis

KW - Vitamin B

UR - http://www.scopus.com/inward/record.url?scp=34447257158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447257158&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2007.02.010

DO - 10.1016/j.ymgme.2007.02.010

M3 - Article

VL - 91

SP - 384

EP - 389

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -